2'-O-PROPARGYL THYMIDINE-5'-MONOPHOSPHATE RNA linking ATOMN C13 H17 N2 O9 P DT 0 2004-12-17 2011-06-04 N REL 376.256 T 2GT Y N 1Y9S RCSB P P 0 1 N N N 10.749 4.067 5.377 2.787 0.324 -4.407 P 2GT 1 O1P O 0 1 N N N 11.961 4.604 4.673 3.659 1.172 -5.286 OP1 2GT 2 O2P O 0 1 N N N 10.921 3.350 6.620 1.198 0.588 -4.548 OP2 2GT 3 O5* O 0 1 N N N 9.747 5.281 5.596 3.063 0.476 -2.819 O5' 2GT 4 C5* C 0 1 N N N 9.479 6.145 4.523 2.282 -0.292 -1.921 C5' 2GT 5 C4* C 0 1 N N R 8.428 7.143 4.925 2.725 0.023 -0.498 C4' 2GT 6 O4* O 0 1 N N N 7.160 6.460 5.106 2.470 1.422 -0.246 O4' 2GT 7 C1* C 0 1 N N R 6.438 7.082 6.161 1.373 1.543 0.675 C1' 2GT 8 N1 N 0 1 N N N 6.258 6.107 7.266 0.452 2.524 0.177 N1 2GT 9 C6 C 0 1 N N N 7.110 5.029 7.466 0.309 2.663 -1.199 C6 2GT 10 C2 C 0 1 N N N 5.200 6.336 8.099 -0.300 3.336 1.055 C2 2GT 11 O2 O 0 1 N N N 4.485 7.315 7.980 -0.225 3.269 2.283 O2 2GT 12 N3 N 0 1 N N N 5.027 5.398 9.095 -1.159 4.248 0.431 N3 2GT 13 C4 C 0 1 N N N 5.827 4.304 9.354 -1.338 4.427 -0.932 C4 2GT 14 O4 O 0 1 N N N 5.576 3.577 10.291 -2.112 5.251 -1.413 O4 2GT 15 C5 C 0 1 N N N 6.949 4.135 8.461 -0.514 3.537 -1.792 C5 2GT 16 C5M C 0 1 N N N 7.884 2.988 8.690 -0.651 3.669 -3.275 C5M 2GT 17 C2* C 0 1 N N R 7.268 8.288 6.624 0.748 0.163 0.786 C2' 2GT 18 O2* O 0 1 N N N 6.939 9.362 5.745 0.137 -0.058 2.041 O2' 2GT 19 CB' C 0 1 N N N 5.693 9.974 6.052 -0.332 -1.396 2.174 CB' 2GT 20 CC' C 0 1 N N N 5.418 11.002 5.044 -0.958 -1.592 3.481 CC' 2GT 21 CD' C 0 1 N N N 5.193 11.831 4.192 -1.472 -1.755 4.554 CD' 2GT 22 C3* C 0 1 N N R 8.666 7.817 6.267 1.940 -0.742 0.560 C3' 2GT 23 O3* O 0 1 N N N 9.613 8.876 6.221 2.742 -0.809 1.739 O3' 2GT 24 O3P O 0 1 N Y N 2.921 -1.270 -4.647 OP3 2GT 25 2HOP H 0 0 N N N 10.154 3.010 7.066 0.799 0.616 -5.443 HOP2 2GT 26 1H5* H 0 1 N N N 9.199 5.590 3.597 1.229 -0.035 -2.051 H5' 2GT 27 2H5* H 0 0 N N N 10.403 6.639 4.141 2.428 -1.352 -2.133 H5'' 2GT 28 H4* H 0 1 N N N 8.448 7.904 4.110 3.804 -0.139 -0.410 H4' 2GT 29 H1* H 0 1 N N N 5.428 7.419 5.830 1.754 1.910 1.633 H1' 2GT 30 H6 H 0 1 N N N 7.969 4.873 6.792 0.928 1.995 -1.790 H6 2GT 31 HN3 H 0 1 N N N 4.221 5.527 9.706 -1.709 4.843 1.045 HN3 2GT 32 1H5M H 0 1 N N N 8.912 3.410 8.785 -1.057 2.748 -3.690 H71 2GT 33 2H5M H 0 1 N N N 7.751 2.248 9.514 0.324 3.866 -3.719 H72 2GT 34 3H5M H 0 1 N N N 7.948 2.415 7.735 -1.320 4.497 -3.510 H73 2GT 35 H2* H 0 1 N N N 7.130 8.603 7.685 -0.000 0.004 -0.000 H2' 2GT 36 1HB' H 0 0 N N N 5.658 10.375 7.092 -1.036 -1.599 1.361 HB'1 2GT 37 2HB' H 0 0 N N N 4.864 9.234 6.145 0.525 -2.065 2.052 HB'2 2GT 38 HD' H 0 1 N N N 4.990 12.578 3.424 -1.928 -1.900 5.505 HD' 2GT 39 H3* H 0 1 N N N 9.123 7.137 7.023 1.675 -1.764 0.277 H3' 2GT 40 H3T H 0 0 N Y N 9.762 9.297 7.060 3.447 -0.153 1.628 HO3' 2GT 41 3HOP H 0 0 N N N -0.767 -0.340 0.446 2.886 -1.617 -5.563 HOP3 2GT 42 doub N N 1 sing N N 2 sing N N 3 sing N N 4 sing N N 5 sing N N 6 sing N N 7 sing N N 8 sing N N 9 sing N N 10 sing N N 11 sing N N 12 sing N N 13 sing N N 14 sing N N 15 sing N N 16 sing N N 17 sing N N 18 doub N N 19 sing N N 20 doub N N 21 sing N N 22 sing N N 23 sing N N 24 doub N N 25 sing N N 26 sing N N 27 sing N N 28 sing N N 29 sing N N 30 sing N N 31 sing N N 32 sing N N 33 sing N N 34 sing N N 35 sing N N 36 sing N N 37 trip N N 38 sing N N 39 sing N N 40 sing N N 41 sing N N 42 sing N N 43 O=C1NC(=O)N(C=C1C)C2OC(C(O)C2OCC#C)COP(=O)(O)O CC1=CN([C@@H]2O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@H]2OCC#C)C(=O)NC1=O CC1=CN([CH]2O[CH](CO[P](O)(O)=O)[CH](O)[CH]2OCC#C)C(=O)NC1=O CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)OCC#C CC1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)OCC#C InChI=1S/C13H17N2O9P/c1-3-4-22-10-9(16)8(6-23-25(19,20)21)24-12(10)15-5-7(2)11(17)14-13(15)18/h1,5,8-10,12,16H,4,6H2,2H3,(H,14,17,18)(H2,19,20,21)/t8-,9-,10-,12-/m1/s1 HARKMJGNXJUASR-DNRKLUKYSA-N 5-methyl-2'-O-prop-2-yn-1-yluridine 5'-(dihydrogen phosphate) [(2R,3R,4R,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)-4-prop-2-ynoxy-oxolan-2-yl]methyl dihydrogen phosphate RCSB RCSB RCSB